Polyfunctional anti-human epidermal growth factor receptor 3 (anti-HER3) antibodies induced by HER3 vaccines have multiple mechanisms of antitumor activity against therapy resistant and triple negative breast cancers

BACKGROUND: Upregulation of human epidermal growth factor receptor 3 (HER3) is a major mechanism of acquired resistance to therapies targeting its heterodimerization partners epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), but also exposes HER3 as a targe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res
Main Authors: Osada, Takuya, Hartman, Zachary C., Wei, Junping, Lei, Gangjun, Hobeika, Amy C., Gwin, William R., Diniz, Marcio A., Spector, Neil, Clay, Timothy M., Chen, Wei, Morse, Michael A., Lyerly, H. Kim
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6085609/
https://ncbi.nlm.nih.gov/pubmed/30092835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-018-1023-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados